• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经上皮角膜交联的体外研究

Ex Vivo Study of Transepithelial Corneal Cross-linking.

作者信息

Cruzat Andrea, Shukla Anita N, Arafat Samer N, Alageel Saleh, Colon Clara, Chodosh James, Ciolino Joseph B

出版信息

J Refract Surg. 2017 Mar 1;33(3):171-177. doi: 10.3928/1081597X-20161206-04.

DOI:10.3928/1081597X-20161206-04
PMID:28264131
Abstract

PURPOSE

To perform in vitro assessment of different techniques of transepithelial corneal cross-linking (CXL) and to compare the results to deepithelialized CXL.

METHODS

Transepithelial CXL was performed after pre-treatment with or without penetration enhancers (gum cellulose, 0.44% sodium chloride, and 0.01% benzalkonium chloride) for 15 or 60 minutes. Deepithelialized corneas underwent CXL after pretreatment with riboflavin for 15 minutes, according to the Dresden protocol. All corneas were incubated in 0.3% collagenase A solution and the time to total dissolution was measured. Corneas were also imaged with confocal microscopy to evaluate the corneal epithelium, subbasal nerve plexus, and depth of stromal keratocyte nuclei as a means of measuring the depth of collagen CXL.

RESULTS

Deepithelialized CXL corneas with 15 minutes of pretreatment dissolved after 15.4 ± 3.1 hours, significantly longer (P = .001) than deepithelialized untreated corneas (8.5 ± 0.6 hours). Transepithelial CXL corneas with 15 minutes of pretreatment with or without penetration enhancers dissolved after 8.3 ± 2.1 and 7.4 ± 1.6 hours, respectively. A longer pretreatment of 60 minutes with penetration enhancers resulted in greater resistance to degradation of the transepithelial CXL corneas (14.6 ± 2.2 hours), which was similar to deepithelialized CXL corneas. The results of the biological assay correlated well with the imaging results obtained by confocal microscopy.

CONCLUSIONS

Corneas treated by transepithelial CXL with an extended pretreatment time of 60 minutes and penetration enhancers exhibited similar characteristics as corneas treated by the deepithelialized CXL approach. By confocal imaging, the transepithelial approach with extended pretreatment time demonstrated evidence of epithelial damage, which may have improved the treatment effect of this group. [J Refract Surg. 2017;33(3):171-177.].

摘要

目的

对不同的经上皮角膜交联(CXL)技术进行体外评估,并将结果与去上皮CXL进行比较。

方法

在使用或不使用渗透促进剂(胶质纤维素、0.44%氯化钠和0.01%苯扎氯铵)预处理15或60分钟后进行经上皮CXL。根据德累斯顿方案,去上皮角膜在使用核黄素预处理15分钟后进行CXL。将所有角膜置于0.3%胶原酶A溶液中,测量完全溶解所需的时间。还使用共聚焦显微镜对角膜进行成像,以评估角膜上皮、基底膜下神经丛和基质角膜细胞核的深度,作为测量胶原CXL深度的一种方法。

结果

预处理15分钟的去上皮CXL角膜在15.4±3.1小时后溶解,明显长于未处理的去上皮角膜(8.5±0.6小时,P = 0.001)。使用或不使用渗透促进剂预处理15分钟的经上皮CXL角膜分别在8.3±2.1和7.4±1.6小时后溶解。使用渗透促进剂进行60分钟的较长预处理导致经上皮CXL角膜的抗降解能力增强(14.6±2.2小时),这与去上皮CXL角膜相似。生物学检测结果与共聚焦显微镜获得的成像结果相关性良好。

结论

经上皮CXL且预处理时间延长至60分钟并使用渗透促进剂处理的角膜表现出与去上皮CXL方法处理的角膜相似的特征。通过共聚焦成像,预处理时间延长的经上皮方法显示出上皮损伤的证据,这可能改善了该组的治疗效果。[《屈光手术杂志》。2017;33(3):171 - 177。]

相似文献

1
Ex Vivo Study of Transepithelial Corneal Cross-linking.经上皮角膜交联的体外研究
J Refract Surg. 2017 Mar 1;33(3):171-177. doi: 10.3928/1081597X-20161206-04.
2
Transepithelial riboflavin/ultraviolet. a corneal cross-linking in keratoconus: morphologic studies on human corneas.经上皮角膜胶原交联术在圆锥角膜中的应用:对人眼角膜的形态学研究。
Am J Ophthalmol. 2013 Nov;156(5):874-884.e1. doi: 10.1016/j.ajo.2013.06.025. Epub 2013 Aug 20.
3
Can the effect of transepithelial corneal collagen cross-linking be improved by increasing the duration of topical riboflavin application? An in vivo confocal microscopy study.通过延长局部应用核黄素的时间能否提高经上皮角膜胶原交联的效果?一项体内共聚焦显微镜研究。
Eye Contact Lens. 2014 Jul;40(4):207-12. doi: 10.1097/ICL.0000000000000036.
4
Corneal confocal microscopy following conventional, transepithelial, and accelerated corneal collagen cross-linking procedures for keratoconus.角膜共焦显微镜检查在常规、经上皮和加速角膜胶原交联程序治疗圆锥角膜中的应用。
J Refract Surg. 2012 Nov;28(11):769-76. doi: 10.3928/1081597X-20121016-01.
5
A New Matrix Therapy Agent for Faster Corneal Healing and Less Ocular Discomfort Following Epi-off Accelerated Corneal Cross-linking in Progressive Keratoconus.一种新型基质疗法药物,用于在进行性圆锥角膜的表层角膜切除术加速角膜交联后实现更快的角膜愈合并减少眼部不适。
J Refract Surg. 2017 Mar 1;33(3):163-170. doi: 10.3928/1081597X-20161206-07.
6
In Vivo Femtosecond Laser Machined Transepithelial Nonlinear Optical Corneal Crosslinking Compared to Ultraviolet Corneal Crosslinking.体内飞秒激光磨除上皮的非线性光学角膜交联术与紫外线角膜交联术的比较。
Transl Vis Sci Technol. 2024 Oct 1;13(10):9. doi: 10.1167/tvst.13.10.9.
7
Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis.用于圆锥角膜的经上皮角膜胶原交联:通过体内HRT II共聚焦分析进行定性研究。
Eur J Ophthalmol. 2012;22 Suppl 7:S81-8. doi: 10.5301/ejo.5000125.
8
Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications.体内共聚焦激光扫描显微镜观察核黄素紫外线A胶原交联术后角膜愈合情况:早期和晚期改变
Am J Ophthalmol. 2008 Oct;146(4):527-533. doi: 10.1016/j.ajo.2008.05.042. Epub 2008 Jul 30.
9
In Vivo Confocal Microscopy After Contact Lens-Assisted Corneal Collagen Cross-linking for Thin Keratoconic Corneas.软性角膜接触镜辅助角膜胶原交联治疗薄圆锥角膜后的体内共聚焦显微镜检查
J Refract Surg. 2016 May 1;32(5):326-31. doi: 10.3928/1081597X-20160225-04.
10
Corneal Nerve Regeneration After Collagen Cross-Linking Treatment of Keratoconus: A 5-Year Longitudinal Study.圆锥角膜胶原交联治疗后的角膜神经再生:一项5年纵向研究。
JAMA Ophthalmol. 2016 Jan;134(1):70-8. doi: 10.1001/jamaophthalmol.2015.4518.

引用本文的文献

1
Enzymatic Digestion of Porcine Corneas Cross-linked by Hypo- and Hyperosmolar Formulations of Riboflavin/ultraviolet A or WST11/Near-Infrared Light.用低渗和高渗核黄素/紫外线A或WST11/近红外光配方交联的猪角膜的酶消化
Transl Vis Sci Technol. 2020 Sep 3;9(10):4. doi: 10.1167/tvst.9.10.4. eCollection 2020 Sep.
2
Current perspectives on corneal collagen crosslinking (CXL).角膜胶原交联(CXL)的当前观点
Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1363-1384. doi: 10.1007/s00417-018-3966-0. Epub 2018 Apr 6.